Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence

Oncogene

Volumn 28, Issue 39, 2009, Pages 3456-3467

  Helmbold, H ^a   Komm N ^a   Deppert, W ^a   Bohn, W ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

DNA damage; P53; Rb2 p130; Senescence

Indexed keywords

CYCLIN A; CYCLIN B; PROTEIN P130; PROTEIN P16; PROTEIN P21; PROTEIN P53;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA DAMAGE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENESCENCE;

CELL AGING; CELL LINE, TUMOR; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; FIBROBLASTS; G1 PHASE; HUMANS; P21-ACTIVATED KINASES; RETINOBLASTOMA-LIKE PROTEIN P130; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349693968     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.222     Document Type: Article

References (41)

1. Araki K, Nakajima Y, Eto K, Ikeda MA. (2003). Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 22: 7632-7641.
2. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P et al. (2003). Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212-4222.
3. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
4. Brown JP, Wei W, Sedivy JM. (1997). Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human .broblasts. Science 277: 831-834.
5. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
6. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y et al. (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761-3767.
7. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC et al. (2000). p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19: 2165-2170.
8. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-de.cient tumorigenesis. Nature 436: 725-730.
9. Cinti C, Macaluso M, Giordano A. (2005). Tumor-specific exon 1 mutations could be the 0hit event0 predisposing Rb2/p130 gene to epigenetic silencing in lung cancer. Oncogene 24: 5821-5826.
10. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. (1994). p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560.
11. Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA. (1993). Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392-2404.
12. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005). Tumour biology: senescence in premalignant tumours. Nature 436: 642.
13. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
14. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identi.es senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
15. Gire V, Wynford-Thomas D. (1998). Reinitiation of DNA synthesis and cell division in senescent human .broblasts by microinjection of anti-p53 antibodies. Mol Cell Biol 18: 1611-1621.
16. Helmbold H, Deppert W, Bohn W. (2006). Regulation of cellular senescence by Rb2/p130. Oncogene 25: 5257-5262.
17. Jackson JG, Pereira-Smith OM. (2006). Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 26: 2501-2510.
18. Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W, Bohn W. (2006). Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 13: 324-334.
19. Khanna KK. (2000). Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92: 795-802.
20. Lacy S, Whyte P. (1997). Identi.cation of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene 14: 2395-2406.
21. Li Q, Sakurai Y, Ryu T, Azuma K, Yoshimura K, Yamanouchi Y et al. (2004). Expression of Rb2/p130 protein correlates with the degree of malignancy in gliomas. Brain Tumor Pathol 21: 121-125.
22. Mallette FA, Ferbeyre G. (2007). The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6: 1831-1836. (Pubitemid 47327900)
23. Malumbres M, Barbacid M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231.
24. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
25. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. (2002). The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-614.
26. Pardee AB. (1974). A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71: 1286-1290.
27. Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio D. (2004). Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 64: 3079-3086. (Pubitemid 38581407)
28. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256.
29. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
30. Shan B, Chang CY, Jones D, Lee WH. (1994). The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol 14: 299-309.
31. Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A et al. (2001). Expression of the retinoblastoma-related gene Rb2/ p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol 32: 360-367.
32. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K et al. (2006). Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291-1297.
33. Takahashi Y, Rayman JB, Dynlacht BD. (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
34. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. (2002). DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883.
35. Tosi GM, Trimarchi C, Macaluso M, La Sala D, Ciccodicola A, Lazzi S et al. (2005). Genetic and epigenetic alterations of RB2/p130
36. tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach. Oncogene 24: 5827-5836.
37. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716.
38. Zalvide J, DeCaprio JA. (1995). Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol 15: 5800-5810.
39. Zhang B, Chen W, Roman A. (2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 103: 437-442.
40. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX et al. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and RbhSWI/ SNF. Cell 101: 79-89.
41. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D et al. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111-1125.